These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 12520255)

  • 1. Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery.
    Park JS; Kim MS; Joung MY; Park HJ; Ho MJ; Choi JH; Seo JH; Song WH; Choi YW; Lee S; Choi YS; Kang MJ
    Int J Nanomedicine; 2022; 17():3673-3690. PubMed ID: 36046838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S; Zielen S
    Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population pharmacokinetic model for montelukast disposition in adults and children.
    Ramakrishnan R; Migoya E; Knorr B
    Pharm Res; 2005 Apr; 22(4):532-40. PubMed ID: 15846460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.
    Mougey EB; Lang JE; Wen X; Lima JJ
    J Clin Pharmacol; 2011 May; 51(5):751-60. PubMed ID: 20974993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence study of montelukast tablets in healthy Pakistani volunteers.
    Abbas M; Khan AM; Amin S; Riffat S; Ashraf M; Waheed N
    Pak J Pharm Sci; 2013 Mar; 26(2):255-9. PubMed ID: 23455193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.
    Kim KA; Park PW; Kim KR; Park JY
    Br J Clin Pharmacol; 2007 Mar; 63(3):339-45. PubMed ID: 16981900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactions.
    Böhmer GM; Nassr N; Wenger M; Hünnemeyer A; Lahu G; Templin S; Gleiter CH; Hermann R
    J Clin Pharmacol; 2009 Apr; 49(4):389-97. PubMed ID: 19318692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast pharmacokinetics in cystic fibrosis.
    Graff GR; Weber A; Wessler-Starman D; Smith AL
    J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast in 2- to 5-year-old children with asthma.
    Skoner D
    Pediatr Pulmonol Suppl; 2001; 21():46-8. PubMed ID: 11475172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.
    Sörgel F; Stephan U; Wiesemann HG; Gottschalk B; Stehr C; Rey M; Böwing HB; Dominick HC; Geldmacher von Mallinckrodt M
    Infection; 1987; 15(5):385-96. PubMed ID: 3319914
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.